Intra-tumour heterogeneity: a looking glass for cancer? (original) (raw)

• Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38, 2651–2660 (1978).
  CAS PubMed Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012). This paper demonstrated substantial spatial genetic heterogeneity within tumours, including synonymous driving mutations independently arising in distinct clones. Furthermore, it reported distinct diagnostic signatures from different biopsies of the same tumour.
  CAS PubMed PubMed Central Google Scholar
• Anderson, K. et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469, 356–361 (2011). This paper demonstrated substantial genetic variability in putative driver mutations between leukaemia stem cells, suggesting complex patterns of clonal evolution.
  CAS PubMed Google Scholar
• Campbell, L. L. & Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6, 2332–2338 (2007).
  CAS PubMed Google Scholar
• Shackleton, M., Quintana, E., Fearon, E. R. & Morrison, S. J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822–829 (2009).
  CAS PubMed Google Scholar
• Notta, F. et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469, 362–367 (2011). This paper demonstrated substantial genetic diversity between leukaemia-initiating cells, suggesting complex clonal architecture.
  CAS PubMed Google Scholar
• Shipitsin, M. et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259–273 (2007). This paper demonstrated that presumed stem cell and non-stem cell subpopulations in breast tumours can have different patterns of mutations.
  CAS PubMed Google Scholar
• Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nature Med. 10, 789–799 (2004).
  CAS PubMed Google Scholar
• Rangarajan, A., Hong, S. J., Gifford, A. & Weinberg, R. A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171–183 (2004).
  CAS PubMed Google Scholar
• Ruiz, C. et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc. Natl Acad. Sci. USA 108, 12054–12059 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ashworth, A., Lord, C. J. & Reis-Filho, J. S. Genetic interactions in cancer progression and treatment. Cell 145, 30–38 (2011).
  CAS PubMed Google Scholar
• Raj, A. & van Oudenaarden, A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135, 216–226 (2008).
  CAS PubMed PubMed Central Google Scholar
• Niepel, M., Spencer, S. L. & Sorger, P. K. Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr. Opin. Chem. Biol. 13, 556–561 (2009).
  CAS PubMed PubMed Central Google Scholar
• Altschuler, S. J. & Wu, L. F. Cellular heterogeneity: do differences make a difference? Cell 141, 559–563 (2010).
  CAS PubMed PubMed Central Google Scholar
• Huang, S. Non-genetic heterogeneity of cells in development: more than just noise. Development 136, 3853–3862 (2009).
  CAS PubMed PubMed Central Google Scholar
• Eldar, A. & Elowitz, M. B. Functional roles for noise in genetic circuits. Nature 467, 167–173 (2010).
  CAS PubMed PubMed Central Google Scholar
• Dalerba, P. et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nature Biotechnol. 29, 1120–1127 (2011).
  CAS Google Scholar
• Clevers, H. The cancer stem cell: premises, promises and challenges. Nature Med. 17, 313–319 (2011).
  CAS PubMed Google Scholar
• Rosen, J. M. & Jordan, C. T. The increasing complexity of the cancer stem cell paradigm. Science 324, 1670–1673 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chaffer, C. L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl Acad. Sci. USA. 108, 7950–7955 (2011).
  CAS PubMed PubMed Central Google Scholar
• Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593–598 (2008).
  CAS PubMed PubMed Central Google Scholar
• Balazsi, G., van Oudenaarden, A. & Collins, J. J. Cellular decision making and biological noise: from microbes to mammals. Cell 144, 910–925 (2011).
  CAS PubMed PubMed Central Google Scholar
• Arias, A. M. & Hayward, P. Filtering transcriptional noise during development: concepts and mechanisms. Nature Rev. Genet. 7, 34–44 (2006).
  CAS PubMed Google Scholar
• Hughes, T. R. et al. Functional discovery via a compendium of expression profiles. Cell 102, 109–126 (2000).
  CAS PubMed Google Scholar
• Luo, J., Solimini, N. L. & Elledge, S. J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823–837 (2009).
  CAS PubMed PubMed Central Google Scholar
• Whitesell, L. & Lindquist, S. L. HSP90 and the chaperoning of cancer. Nature Rev. Cancer 5, 761–772 (2005).
  CAS Google Scholar
• Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884–901 (2010).
  CAS PubMed PubMed Central Google Scholar
• Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17–32 (2004).
  CAS PubMed Google Scholar
• Tlsty, T. D. & Coussens, L. M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119–150 (2006).
  CAS PubMed Google Scholar
• Bissell, M. J., Kenny, P. A. & Radisky, D. C. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb. Symp. Quant. Biol. 70, 343–356 (2005).
  CAS PubMed PubMed Central Google Scholar
• Anderson, A. R., Weaver, A. M., Cummings, P. T. & Quaranta, V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127, 905–915 (2006).
  CAS PubMed Google Scholar
• Chen, J., Sprouffske, K., Huang, Q. & Maley, C. C. Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PloS ONE 6, e17933 (2011).
  CAS PubMed PubMed Central Google Scholar
• Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Rev. Cancer 9, 265–273 (2009).
  CAS Google Scholar
• Hendrix, M. J., Seftor, E. A., Hess, A. R. & Seftor, R. E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature Rev. Cancer 3, 411–421 (2003).
  CAS Google Scholar
• Radisky, D. C. & Bissell, M. J. Matrix metalloproteinase-induced genomic instability. Curr. Opin. Genet. Dev. 16, 45–50 (2006).
  CAS PubMed Google Scholar
• Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071–1121 (2011).
  CAS PubMed Google Scholar
• Farmer, P. et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Med. 15, 68–74 (2009).
  CAS PubMed Google Scholar
• Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nature Med. 14, 518–527 (2008).
  CAS PubMed Google Scholar
• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  CAS PubMed Google Scholar
• Merlo, L. M., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary and ecological process. Nature Rev. Cancer 6, 924–935 (2006).
  CAS Google Scholar
• Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683–692 (2007).
  CAS PubMed PubMed Central Google Scholar
• Brock, A., Chang, H. & Huang, S. Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours. Nature Rev. Genetics 10, 336–342 (2009).
  CAS Google Scholar
• Weinberg, R. A. The Biology of Cancer (Garland Science, 2007).
  Google Scholar
• Barrick, J. E. & Lenski, R. E. Genome-wide mutational diversity in an evolving population of Escherichia coli. Cold Spring Harb. Symp. Quant. Biol. 74, 119–129 (2009).
  CAS PubMed PubMed Central Google Scholar
• Desai, M. M., Fisher, D. S. & Murray, A. W. The speed of evolution and maintenance of variation in asexual populations. Curr. Biol. 17, 385–394 (2007).
  CAS PubMed PubMed Central Google Scholar
• Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105–117 (2010).
  CAS PubMed Google Scholar
• Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011). The first report that interrogated genomic-wide diversity within tumours on a single-cell level.
  CAS PubMed PubMed Central Google Scholar
• Tsao, J. L. et al. Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am. J. Pathol. 154, 1815–1824 (1999).
  CAS Google Scholar
• Gonzalez-Garcia, I., Sole, R. V. & Costa, J. Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl Acad. Sci. USA 99, 13085–13089 (2002).
  CAS PubMed PubMed Central Google Scholar
• Snuderl, M. et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20, 810–817 (2011).
  CAS PubMed Google Scholar
• Stoecklein, N. H. & Klein, C. A. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int. J. Cancer. 126, 589–598 (2010).
  CAS PubMed Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  CAS PubMed Google Scholar
• Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003).
  CAS PubMed Google Scholar
• Weigelt, B. et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 65, 9155–9158 (2005).
  CAS PubMed Google Scholar
• Klein, C. A. Parallel progression of primary tumours and metastases. Nature Rev. Cancer 9, 302–312 (2009).
  CAS Google Scholar
• Mardis, E. R. Cancer genomics identifies determinants of tumor biology. Genome Biol. 11, 211 (2010).
  PubMed PubMed Central Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809–813 (2009). The first report that used next-generation sequencing to interrogate clonal diversity and evolution during breast cancer progression.
  CAS PubMed Google Scholar
• Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999–1005 (2010).
  CAS PubMed PubMed Central Google Scholar
• Perou, C. M., Parker, J. S., Prat, A., Ellis, M. J. & Bernard, P. S. Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncol. 11, 718–719 (2010).
  PubMed Google Scholar
• Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869–10874 (2001).
  CAS PubMed PubMed Central Google Scholar
• Komaki, K., Sano, N. & Tangoku, A. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast cancer 13, 249–253 (2006).
  PubMed Google Scholar
• Bertos, N. R. & Park, M. Breast cancer - one term, many entities? J. Clin. Invest. 121, 3789–3796 (2011).
  CAS PubMed PubMed Central Google Scholar
• Allred, D. C. et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin. Cancer Res. 14, 370–378 (2008).
  CAS PubMed Google Scholar
• Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet. 38, 468–473 (2006). This paper linked higher extent of genetic clonal diversity with poor clinical outcome.
  CAS PubMed Google Scholar
• Merlo, L. M. & Maley, C. C. The role of genetic diversity in cancer. J. Clin. Invest. 120, 401–403 (2010).
  CAS PubMed PubMed Central Google Scholar
• Park, S. Y. et al. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin. Cancer Res. 16, 876–887 (2010).
  CAS PubMed PubMed Central Google Scholar
• Meads, M. B., Gatenby, R. A. & Dalton, W. S. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nature Rev. Cancer 9, 665–674 (2009).
  CAS Google Scholar
• Ebos, J. M. et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232–239 (2009).
  CAS PubMed PubMed Central Google Scholar
• Paez-Ribes, M. et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220–231 (2009).
  CAS PubMed PubMed Central Google Scholar
• Deininger, M. Resistance to imatinib: mechanisms and management. J. Natl Compr. Canc. Netw. 3, 757–768 (2005).
  PubMed Google Scholar
• Corless, C. L. & Heinrich, M. C. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu. Rev. Pathol. 3, 557–586 (2008).
  CAS PubMed Google Scholar
• Nazarian, R. et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 468, 973–977 (2010).
  CAS PubMed PubMed Central Google Scholar
• Engelman, J. A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316, 1039–1043 (2007).
  CAS PubMed Google Scholar
• Edwards, S. L. et al. Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451, 1111–1115 (2008).
  CAS PubMed Google Scholar
• Sakai, W. et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451, 1116–1120 (2008).
  CAS PubMed PubMed Central Google Scholar
• Roche-Lestienne, C., Lai, J. L., Darre, S., Facon, T. & Preudhomme, C. A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. N. Engl. J. Med. 348, 2265–2266 (2003).
  PubMed Google Scholar
• Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mullighan, C. G. et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377–1380 (2008).
  CAS PubMed PubMed Central Google Scholar
• Glasspool, R. M., Teodoridis, J. M. & Brown, R. Epigenetics as a mechanism driving polygenic clinical drug resistance. Br. J. Cancer 94, 1087–1092 (2006).
  CAS PubMed PubMed Central Google Scholar
• Janne, P. A., Gray, N. & Settleman, J. Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nature Rev. Drug Discov. 8, 709–723 (2009).
  CAS Google Scholar
• Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69–80 (2010). This study linked therapy resistance with a distinct epigenetic switch that arises through a spontaneous phenotypic switch. Although this phenotypic state is reversible, it can persist for multiple cell generations and thus serve as a substrate for Darwinian selection.
  CAS PubMed PubMed Central Google Scholar
• Cohen, A. A. et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 322, 1511–1516 (2008).
  CAS PubMed Google Scholar
• Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M. & Sorger, P. K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459, 428–432 (2009). This study implicated noise-driven stochastic non-genetic variability in short-term resistance to therapy.
  CAS PubMed PubMed Central Google Scholar
• Heppner, G. H. Cancer cell societies and tumor progression. Stem Cells 11, 199–203 (1993).
  CAS PubMed Google Scholar
• Bonavia, R., Inda, M. M., Cavenee, W. K. & Furnari, F. B. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 71, 4055–4060 (2011).
  CAS PubMed PubMed Central Google Scholar
• Park, S. Y., Gönen, M., Kim, H. J., Michor, F. & Polyak, K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest. 120, 636–644 (2010).
  CAS PubMed PubMed Central Google Scholar
• Merlo, L. M. et al. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. (Phila) 3, 1388–1397 (2010).
  Google Scholar
• Russnes, H. G., Navin, N., Hicks, J. & Borresen-Dale, A. L. Insight into the heterogeneity of breast cancer through next-generation sequencing. J. Clin. Invest. 121, 3810–3818 (2011).
  CAS Google Scholar
• Navin, N. et al. Inferring tumor progression from genomic heterogeneity. Genome Res. 20, 68–80 (2010).
  CAS PubMed PubMed Central Google Scholar
• Xu, X. et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148, 886–895 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hou, Y. et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148, 873–885 (2012).
  CAS PubMed Google Scholar
• Miller, B. E., Machemer, T., Lehotan, M. & Heppner, G. H. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Res. 51, 4378–4387 (1991).
  CAS PubMed Google Scholar
• Calbo, J. et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19, 244–256 (2011).
  CAS PubMed Google Scholar
• Marks, P. A. & Dokmanovic, M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin. Investig. Drugs 14, 1497–1511 (2005).
  CAS PubMed Google Scholar
• Gregory, R. I. & Shiekhattar, R. Chromatin modifiers and carcinogenesis. Trends Cell. Biol. 14, 695–702 (2004).
  CAS PubMed Google Scholar
• Bissell, M. J. & Hines, W. C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Med. 17, 320–329 (2011).
  CAS PubMed Google Scholar
• Attolini, C. S. & Michor, F. Evolutionary theory of cancer. Ann. NY Acad. Sci. 1168, 23–51 (2009).
  CAS PubMed Google Scholar
• DeGregori, J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 71, 3739–3744 (2011).
  CAS PubMed PubMed Central Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gatenby, R. A., Silva, A. S., Gillies, R. J. & Frieden, B. R. Adaptive therapy. Cancer Res. 69, 4894–4903 (2009). This paper proposes 'adaptive therapy', which takes into account clonal competition in order to prevent therapy-resistant cells from taking over the population.
  CAS PubMed PubMed Central Google Scholar
• Waddington, C. H. The Strategy of the Genes: a Discussion of Some Aspects of Theoretical Biology (Taylor & Francis, 1957).
  Google Scholar
• Huang, S. & Kauffman, S. A. in Encyclopedia of Complexity and Systems Science (ed. Meyers, R. A.) 1180–1213 (Springer, 2009).
  Google Scholar
• Fisher, A. G. Cellular identity and lineage choice. Nature Rev. Immunol. 2, 977–982 (2002).
  CAS Google Scholar
• Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA 107, 18545–18550 (2010).
  CAS PubMed PubMed Central Google Scholar
• Leedham, S. J. et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 57, 1041–1948 (2008).
  CAS PubMed Google Scholar
• Kim, M. Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315–1326 (2009).
  PubMed PubMed Central Google Scholar